Comparison of two treatment regimens in reduction of proteinuria in diabetic patients

Not Applicable

• Conditions: Diabetic nephropathy.; Glomerular disorders in diabetes mellitus; N08.3*

• Registration Number: IRCT2012121311743N1
• Lead Sponsor: Tabriz University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 44

Inclusion Criteria

(to be 18 to 70 years old; to have type 2 diabetes; 24 hours urine albumin more than 300 mg/dl or to have a albumin to creatinine ratio of more than 30; not to have a nephropathy due to other diseases)
Exclusion criteria: (patients with advanced cardiac or cerebral diseases; to have a history of diabetic ketoacidosis and to have a history of sensitivity to the Vitamin B group drugs)

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serum creatinine level. Timepoint: Before and after treatment. Method of measurement: Lab.;Serum sodium level. Timepoint: before and after treatment. Method of measurement: Lab.;Serum potassium level. Timepoint: before and after treatment. Method of measurement: Lab.;Serum urea level. Timepoint: before and after treatment. Method of measurement: Lab.;Serum cholesterol level. Timepoint: before and after treatment. Method of measurement: Lab.;Serum uric acid level. Timepoint: before and after treatment. Method of measurement: Lab.;Serum triglyceride level. Timepoint: before and after treatment. Method of measurement: Lab.;Urine creatinine level. Timepoint: before and after treatment. Method of measurement: Lab.;24 hours urine albumin level. Timepoint: before and after treatment. Method of measurement: Lab.;24 hours urine protein level. Timepoint: before and after treatment. Method of measurement: Lab.